ATE116363T1 - Verfahren zur herstellung des menschlichen gewebeplasminogenaktivators. - Google Patents

Verfahren zur herstellung des menschlichen gewebeplasminogenaktivators.

Info

Publication number
ATE116363T1
ATE116363T1 AT89310134T AT89310134T ATE116363T1 AT E116363 T1 ATE116363 T1 AT E116363T1 AT 89310134 T AT89310134 T AT 89310134T AT 89310134 T AT89310134 T AT 89310134T AT E116363 T1 ATE116363 T1 AT E116363T1
Authority
AT
Austria
Prior art keywords
plasminogen activator
human tissue
tpa
tissue plasminogen
producing human
Prior art date
Application number
AT89310134T
Other languages
English (en)
Inventor
Shoichiro Miyahara
Atsunori Shindo
Maki Suzuki
Nobumi Kusuhara
Nobuyoshi Makiguchi
Original Assignee
Mitsui Toatsu Chemicals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP63249081A external-priority patent/JP2648624B2/ja
Priority claimed from JP63316118A external-priority patent/JP2718726B2/ja
Application filed by Mitsui Toatsu Chemicals filed Critical Mitsui Toatsu Chemicals
Application granted granted Critical
Publication of ATE116363T1 publication Critical patent/ATE116363T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AT89310134T 1988-10-04 1989-10-04 Verfahren zur herstellung des menschlichen gewebeplasminogenaktivators. ATE116363T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63249081A JP2648624B2 (ja) 1988-10-04 1988-10-04 ヒト組織型プラスミノーゲン活性化因子の製造方法
JP63316118A JP2718726B2 (ja) 1988-12-16 1988-12-16 ヒト組織型プラスミノーゲン活性化因子の製法

Publications (1)

Publication Number Publication Date
ATE116363T1 true ATE116363T1 (de) 1995-01-15

Family

ID=26539082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89310134T ATE116363T1 (de) 1988-10-04 1989-10-04 Verfahren zur herstellung des menschlichen gewebeplasminogenaktivators.

Country Status (11)

Country Link
US (1) US5183754A (de)
EP (1) EP0366285B1 (de)
KR (1) KR920007398B1 (de)
AT (1) ATE116363T1 (de)
AU (1) AU614429B2 (de)
CA (1) CA1335188C (de)
DE (1) DE68920269T2 (de)
DK (1) DK488489A (de)
FI (1) FI96039C (de)
NO (1) NO175787C (de)
NZ (1) NZ230856A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151359A (en) * 1988-05-19 1992-09-29 Mitsui Toatsu Chemicals Incorporated Method for producing of human tissue type plasminogen activator
EP2686423A4 (de) 2011-03-14 2015-01-28 Nat Res Council Canada Verfahren zur herstellung von viren in zellen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732146A (en) * 1970-12-22 1973-05-08 Behringwerke Ag Process for the isolation of native, highly purified plasminogen
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
US4740461A (en) * 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
US4724206A (en) * 1984-02-13 1988-02-09 Damon Biotech, Inc. Protein production using hypertonic media
US4661453A (en) * 1984-06-19 1987-04-28 American Biogenetic Sciences, Inc. Production of tissue plasminogen activator factor
JPS624233A (ja) * 1985-07-01 1987-01-10 Toyobo Co Ltd 組織性プラスミノ−ゲン活性化因子の製造法
US4960702A (en) * 1985-09-06 1990-10-02 Codon Methods for recovery of tissue plasminogen activator
CA1312030C (en) * 1987-11-18 1992-12-29 Brian Maiorella Method to increase antibody titer
US5151359A (en) * 1988-05-19 1992-09-29 Mitsui Toatsu Chemicals Incorporated Method for producing of human tissue type plasminogen activator

Also Published As

Publication number Publication date
FI894657L (fi) 1990-04-05
DE68920269D1 (de) 1995-02-09
NO175787B (no) 1994-08-29
NO175787C (no) 1994-12-07
FI96039C (fi) 1996-04-25
DE68920269T2 (de) 1995-05-18
EP0366285A1 (de) 1990-05-02
EP0366285B1 (de) 1994-12-28
AU4254189A (en) 1990-04-12
US5183754A (en) 1993-02-02
KR920007398B1 (ko) 1992-08-31
DK488489A (da) 1990-04-05
DK488489D0 (da) 1989-10-04
NZ230856A (en) 1991-10-25
FI96039B (fi) 1996-01-15
KR900006509A (ko) 1990-05-08
AU614429B2 (en) 1991-08-29
NO893929L (no) 1990-04-05
FI894657A0 (fi) 1989-10-02
NO893929D0 (no) 1989-10-03
CA1335188C (en) 1995-04-11

Similar Documents

Publication Publication Date Title
ATE59410T1 (de) Verfahren zur herstellung von menschlichem tpa und expressionsvektoren dafuer.
ATE80033T1 (de) Oxygenierter fluorkohlenstoff zur verwendung in intra-peritonialen perfusionen.
ATE159288T1 (de) Verfahren zur herstellung eines menschlichen thrombin-konzentrats für therapeutische verwendung
ES547416A0 (es) Un metodo de producir activador de plasminogeno de tejido uterino humano
AU8039394A (en) Methods for increasing extracellular adenosine and for stabilization mast cells
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
SE8105079L (sv) Antibiotikum bmg162-af2
ATE116363T1 (de) Verfahren zur herstellung des menschlichen gewebeplasminogenaktivators.
DE68916857D1 (de) Verfahren zur Herstellung von menschlichem Gewebeplasminogenaktivator.
ATE397088T1 (de) Verfahren zur herstellung von (s)- oder (r)-3,3,3-trifluor-2-hydroxy-2-methylpropionsaü e
ATE12221T1 (de) Verfahren zur hestellung von einem glutaraldehydvorlaeufer.
ATE196088T1 (de) Verfahren zur gewinnnung von zellkulturen mit erhöhtem gehalt an körpereigenen zytokinen
ATE212977T1 (de) Verfahren zur herstellung von kreatin oder kreatinmonohydrat
LU90993I2 (fr) Xigris-drotrécogine alfa(activée) et ses dérivés pharmaceutiquement acceptables
ATE112308T1 (de) Verfahren zur herstellung von proteinen.
ZA814234B (en) 1-s-alkyl-2-0-acyl-3-phosphocholine-1-mercapto-2.3-propandiols process for producing the same and pharmaceutical preparations containing the same
ATE37873T1 (de) Verfahren zur herstellung optisch aktiver 1,4dihydropyridine.
DE3574675D1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
JPS5244051A (en) Filthy water purifying system
ATE178093T1 (de) Verfahren zur herstellung von neuraminidase
JPS57159484A (en) Cultivating method of dunaliella (green alga)
JPS6427472A (en) Production of human tissue plasminogen activator and cell strain using therein
JPS55150900A (en) Production of interferon
SU758774A1 (ru) Минимальная питательная среда для выращивания возбудителя сапа
SU1207140A1 (ru) Питательная среда для выращивания патогенных лептоспир

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee